182 related articles for article (PubMed ID: 12094630)
1. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.
McMillan DC; Elahi MM; Sattar N; Angerson WJ; Johnstone J; McArdle CS
Nutr Cancer; 2001; 41(1-2):64-9. PubMed ID: 12094630
[TBL] [Abstract][Full Text] [Related]
2. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer.
Elahi MM; McMillan DC; McArdle CS; Angerson WJ; Sattar N
Nutr Cancer; 2004; 48(2):171-3. PubMed ID: 15231451
[TBL] [Abstract][Full Text] [Related]
3. The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma.
Elahi MM; McMillan DC; McArdle CS; Angerson WJ; Soukop M; Johnstone J; Sattar N
Med Sci Monit; 2005 Feb; 11(2):CR75-8. PubMed ID: 15668636
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
McMillan DC; Canna K; McArdle CS
Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
[TBL] [Abstract][Full Text] [Related]
6. Is C-reactive protein a prognostic factor of colorectal cancer?
Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
[TBL] [Abstract][Full Text] [Related]
7. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
[TBL] [Abstract][Full Text] [Related]
8. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.
McMillan DC; Talwar D; Sattar N; Underwood M; O'Reilly DS; McArdle C
Clin Nutr; 2002 Apr; 21(2):161-4. PubMed ID: 12056790
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up.
McArdle PA; Qayyum T; McMillan DC
Urol Int; 2010; 84(4):430-5. PubMed ID: 20395655
[TBL] [Abstract][Full Text] [Related]
10. [C-reactive protein, risk of and survival after cancer--secondary publication].
Allin KH; Bojesen SE; Nordestgaard BG
Ugeskr Laeger; 2009 Nov; 171(48):3510-3. PubMed ID: 19953727
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer.
Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC
Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754
[TBL] [Abstract][Full Text] [Related]
12. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
[TBL] [Abstract][Full Text] [Related]
14. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
[TBL] [Abstract][Full Text] [Related]
15. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
18. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM
Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189
[TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.
Canna K; McMillan DC; McKee RF; McNicol AM; Horgan PG; McArdle CS
Br J Cancer; 2004 May; 90(9):1707-9. PubMed ID: 15150596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
